MedBen Rx Strategies Help Employers Face Pricing Challenges

A recent Washington Post article highlights the machinations that drug companies will use to ensure that insurers and other private-sector sources pay for their products, rather than price-controlled public services like Medicare. One common manufacturer practice is...

MedBen Rx Advocate Closes the Price Gap

Newly appointed Health and Human Services Secretary Alex Azar says he wants to see greater transparency in drug pricing. In an address to the Federation of American Hospitals last month, Azar noted that “in both healthcare services and pharmaceuticals, the huge gaps...

A Note from Our Chairman and President

To our customers, consultants, and brokers: Welcome to 2018! For MedBen, the coming year carries a special significance, as we will celebrate our 80th anniversary in May. As with any benchmark anniversary, it gives us a chance to look back at how we’ve grown, and what...